Systemic effects of vaginally administered estrogen therapy: a review.

Article Details

Citation
Copy to clipboard

Krause M, Wheeler TL 2nd, Richter HE, Snyder TE

Systemic effects of vaginally administered estrogen therapy: a review.

Female Pelvic Med Reconstr Surg. 2010 May;16(3):188-95. doi: 10.1097/SPV.0b013e3181d7e86e.

PubMed ID
22453284 [ View in PubMed
]
Abstract

Hormone therapy was considered the standard of care before the publication of the Women's Health Initiative. After the study was published, the use of systemic hormone therapy dramatically decreased resulting in an increased incidence of menopausal symptoms such as hot flashes, vaginal dryness, and dyspareunia experienced by women. Use of vaginal estrogen offers women a unique alternative for relief of these symptoms. This article reviews the systemic effects of vaginally administered estrogen. Effects on serum hormone levels, vasomotor symptoms, lipid profiles, and use in women with breast cancer are reviewed. An accompanying review (J Pelvic Med Surg. 2009;15:105-114.) examines the local effects of vaginally administered estrogen.

DrugBank Data that Cites this Article

Drugs